|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net loss | |||||
| Net loss from discontinued operation | |||||
| Net loss from continuing operations | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Accretion of debt discount and amortization of deferred financing costs | |||||
| Gain on change in fair value of warrant liability | |||||
| Gain on sale of digital assets | |||||
| Impairment of digital assets | |||||
| Impairment of goodwill and other long lived assets | |||||
| Gain on extinguishment of debt | |||||
| Non-cash writeoff of accounts payable | |||||
| Impairment of goodwill | |||||
| Stock based compensation | |||||
| Other adjustments | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Accrued expenses | |||||
| Accounts payable and accrued expenses | |||||
| Lease liability payments | |||||
| Deferred revenue | |||||
| Net cash used in operating activities from continued operations | |||||
| Net cash used in operating activities from discontinued operations | |||||
| Net cash used in operating activities | |||||
| Investing activities | |||||
| Proceeds received from sale of digital currencies | |||||
| Purchases of digital assets | |||||
| Capital expenditures | |||||
| Net cash provided by investing activities - continuing operations | |||||
| Net cash used in investing activities - discontinued operation | |||||
| Net cash for investing activities | |||||
| Financing activities | |||||
| Proceeds from borrowings, net of issuance costs | |||||
| Payments on borrowings | |||||
| Proceeds from sales of common stock, net of issuance costs | |||||
| Treasury stock repurchases | |||||
| Proceeds from exercise of options to purchase common stock | |||||
| Payments on stock repurchases | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rate on cash and restricted cash | |||||
| Effect of exchange rate on cash | |||||
| Net (decrease) increase in cash and cash equivalents | |||||
| Cash and cash equivalents at the beginning of the period | |||||
| Cash and cash equivalents at the end of the period | |||||
| Supplemental disclosures of non-cash financing activities: | |||||
| Issuance of common stock upon conversion of the 2022 Promissory Note | |||||
| Right-of-use assets obtained in exchange for operating lease obligations | |||||
| Issuance of common stock for payment of bonuses and consulting fees | |||||
| Non-cash exchange of digital assets | |||||
| Issuance of common stock in connection with acquisition of Lyte Technology, Inc. | |||||
| Issuance of common stock under the 2018 Employee Stock Purchase Plan, previously accrued | |||||
| Interest paid | |||||
| Income taxes paid | |||||
Loading...